Article
DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
Journal of translational medicine - 1 Apr 2022
Song Dandan, Wang Xiaosheng
Abstract excerpt
BACKGROUND: Intratumor heterogeneity (ITH) is associated with tumor progression, unfavorable prognosis, immunosuppression, genomic instability, and therapeutic resistance. Thus, evaluation of ITH levels is valuable in cancer diagnosis and treatment. METHODS: We proposed a new mRNA-based ITH evaluation algorithm (DEPTH2) without reference to normal controls. DEPTH2 evaluates ITH levels based on the standard...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
